rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study

Blood Cell ◽

Cell Transplantation ◽

Red Blood Cell ◽

High Dose ◽

High Dose Therapy ◽

TRANSPLANTATION AND CELLULAR ENGINEERING: Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk

Transfusion ◽

10.1111/j.1537-2995.2009.02461.x ◽

2009 ◽

Vol 50 (3) ◽

pp. 649-655 ◽

Cited By ~ 13

Author(s):

Daphne Dahl ◽

Andreas Hahn ◽

Christian Koenecke ◽

Hans-Gert Heuft ◽

Elke Dammann ◽

...

Keyword(s):

At Risk ◽

Stem Cell ◽

Blood Cell ◽

Cell Transplantation ◽

Red Blood Cell ◽

Transfusion Requirement ◽

Patients At Risk ◽

Blood Stem Cell Transplantation

Progressive Intermediate-Grade Non-Hodgkin's Lymphoma After High-Dose Therapy and Autologous Peripheral Stem-Cell Transplantation: Changing the Natural History with Monoclonal Antibody Therapy

Clinical Lymphoma ◽

10.3816/clm.2000.n.006 ◽

2000 ◽

Vol 1 (1) ◽

pp. 62-66 ◽

Cited By ~ 6

Author(s):

Donald E. Tsai ◽

Stephen J. Schuster ◽

Alexander Matthies ◽

Halle C.F. Moore ◽

Abass Alavi ◽

...

Keyword(s):

Monoclonal Antibody ◽

Stem Cell ◽

Natural History ◽

Cell Transplantation ◽

Antibody Therapy ◽

High Dose ◽

Monoclonal Antibody Therapy ◽

High Dose Therapy ◽

Impact of a Conservative Red Blood Cell Transfusion Strategy in Children Undergoing Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2011.10.043 ◽

2012 ◽

Vol 18 (5) ◽

pp. 813-817 ◽

Cited By ~ 11

Author(s):

Jenifer R. Lightdale ◽

Adrienne G. Randolph ◽

Chau M. Tran ◽

Hongyu Jiang ◽

Andrea Colon ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Blood Cell ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Red Blood Cell ◽

Transfusion Strategy ◽

Hematopoietic Stem

Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral stem cell transplantation

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1701944 ◽

1999 ◽

Vol 24 (5) ◽

pp. 521-526 ◽

Cited By ~ 27

Author(s):

DE Tsai ◽

HCF Moore ◽

CL Hardy ◽

DL Porter ◽

EY Loh ◽

...

Keyword(s):

Monoclonal Antibody ◽

Stem Cell ◽

Cell Transplantation ◽

Antibody Therapy ◽

High Dose ◽

Monoclonal Antibody Therapy ◽

High Dose Therapy ◽

Peripheral Stem Cell Transplantation ◽

Anti Cd20

Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation

Transfusion ◽

10.1111/j.1537-2995.2011.03552.x ◽

2012 ◽

Vol 52 (9) ◽

pp. 2049-2054 ◽

Cited By ~ 7

Author(s):

Natasha Kekre ◽

Grace Christou ◽

Ranjeeta Mallick ◽

Melanie Tokessy ◽

Alan Tinmouth ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Blood Cell ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Red Blood Cell ◽

Hematopoietic Stem ◽

Factors Associated

Impact of a Prudent© Conservative Red Blood Cell Transfusion Strategy in Children Undergoing Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2010.12.339 ◽

2011 ◽

Vol 17 (2) ◽

pp. S266 ◽

Cited By ~ 1

Author(s):

J.R. Lightdale ◽

C.M. Tran ◽

A.G. Randolph ◽

H. Jiang ◽

A. Colon ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Blood Cell ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Red Blood Cell ◽

Transfusion Strategy ◽

Hematopoietic Stem

The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]

Blood ◽

10.1182/blood.v77.2.211.bloodjournal772211 ◽

1991 ◽

Vol 77 (2) ◽

pp. 211-213 ◽

Cited By ~ 2

Author(s):

A Kessinger ◽

JO Armitage

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Peripheral Stem Cell ◽

The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]

Blood ◽

10.1182/blood.v77.2.211.211 ◽

1991 ◽

Vol 77 (2) ◽

pp. 211-213 ◽

Cited By ~ 199

Author(s):

A Kessinger ◽

JO Armitage

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Peripheral Stem Cell ◽

Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation

Haematologica ◽

10.3324/haematol.2011.047035 ◽

2011 ◽

Vol 97 (1) ◽

pp. 116-122 ◽

Cited By ~ 53

Author(s):

M. D. Berger ◽

B. Gerber ◽

K. Arn ◽

O. Senn ◽

U. Schanz ◽

...

Keyword(s):

Stem Cell ◽

Blood Cell ◽

Cell Transplantation ◽

Red Blood Cell ◽

Single Unit ◽

Intensive Chemotherapy ◽

Transfusion Requirements

A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)

Annals of Hematology ◽

10.1007/s00277-002-0495-y ◽

2002 ◽

Vol 81 (8) ◽

pp. 424-429 ◽

Cited By ~ 10

Author(s):

J.-P. Glossmann ◽

A. Josting ◽

B. Pfistner ◽

U. Paulus ◽

A. Engert

Keyword(s):

Stem Cell ◽

Randomized Trial ◽

Cell Transplantation ◽

Hodgkin’S Disease ◽

Single Agent ◽

High Dose Chemotherapy ◽

High Dose ◽

Peripheral Stem Cell ◽